JAK-IN-20

Modify Date: 2025-08-28 16:15:02

JAK-IN-20 Structure
JAK-IN-20 structure
Common Name JAK-IN-20
CAS Number 1654776-91-6 Molecular Weight 515.58
Density N/A Boiling Point N/A
Molecular Formula C28H30FN7O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of JAK-IN-20


JAK-IN-20 is a potent, pan and orally active JAK inhibitor with an IC50s of 7 nM, 5 nM, 14 nM for JAK1, JAK2, JAK3, respectively. JAK-IN-20 shows excellent pharmacokinetics and displays anti-inflammatory efficacy in vivo[1].

 Names

Name JAK-IN-20

 JAK-IN-20 Biological Activity

Description JAK-IN-20 is a potent, pan and orally active JAK inhibitor with an IC50s of 7 nM, 5 nM, 14 nM for JAK1, JAK2, JAK3, respectively. JAK-IN-20 shows excellent pharmacokinetics and displays anti-inflammatory efficacy in vivo[1].
Related Catalog
Target

JAK1:7 nM (IC50)

JAK2:5 nM (IC50)

JAK3:14 nM (IC50)

In Vivo JAK-IN-20 (compound 32) (3 mg/kg for p.o.; 1 mg/kg for i.v.) shows excellent pharmacokinetics in rats[1]. JAK-IN-20 (10 mg/kg; p.o.; once a day for 3 days) shows anti-inflammatory effect[1]. Pharmacokinetic Parameters of JAK-IN-20 in female Sprague Dawley rats[1]. parameter 32 PO Dose (mg/kg) 3 Tmax (h) 0.63(0.25-6) Cmax (µg/mL) 7.82±3.68 AUC0-t (µg.h/mL) 80.18±35.44 T1/2,po (h) 4.77±1.84 MRT (h) 7.54±2.52 IV Dose (mg/kg) 1 C0 (µg/mL) 4.70±2.50 AUC0-t (µg.h/mL) 18.89±1.76 Vss (L/kg) 0.32±0.14 CL (mL/min/kg) 0.85±0.13 T1/2,iv (h) 5.16±3.83 MRT (h) 6.69±4.03 %F 100Wistar rats; 3 mg/kg; p.o. (1% Tween 80 + 99% (0.5%) methyl cellulose in water); 1 mg/kg; i.v. (5% NMP + 5% solutol + 90% normal saline)[1] Animal Model: 7-10 weeks, 250-300g, male wistar rats[1] Dosage: Administration: 3 mg/kg for p.o.; 1 mg/kg for i.v. Result: Showed fast oral absorption, higher plasma exposure, extended oral half-life and excellent oral bioavailability of 100%. Animal Model: Female Sprague Dawley rats ( PGPS rat model)[1] Dosage: 10 mg/kg Administration: P.o.; once a day; 3 days Result: Showed anti-inflammatory effect.
References

[1]. Desai J, et al. Optimisation of momelotinib with improved potency and efficacy as pan-JAK inhibitor. Bioorg Med Chem Lett. 2022; 66:128728.

 Chemical & Physical Properties

Molecular Formula C28H30FN7O2
Molecular Weight 515.58
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.